Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-01 Purchase |
2024-02-06 10:27 am |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
33,333 | $0.3 | $10,000 | 224,313 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-08 Option Award |
2024-04-10 9:52 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
35,000 | $0 | 276,688 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-06 10:27 am |
2024-02-01 2029-02-01 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
66,666 | $0 | 224,313 (Direct) |
View |
| 2023-09-21 Option Award(A) |
2023-10-12 6:01 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
39,475 | $0 | 45,428 (Direct) |
View |
| 2023-09-21 Option Award |
2023-09-25 6:24 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
68,961 | $0 | 74,914 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-09 2:34 pm |
N/A N/A |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
3,750 | $0.268 | 3,750 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-16 5:00 pm |
N/A 2031-07-15 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
32,000 | $0 | 178,559 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-16 5:23 pm |
N/A 2030-06-12 |
CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director |
46,559 | $0 | 146,559 (Direct) |
View |